Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
31.00
+1.50 (5.08%)
Aug 14, 2025, 4:45 PM CET
5.08%
Market Cap137.57M
Revenue (ttm)250.00K
Net Income (ttm)-20.83M
Shares Out4.66M
EPS (ttm)-4.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume737
Average Volume3,218
Open30.70
Previous Close29.50
Day's Range30.40 - 31.00
52-Week Range28.50 - 56.80
Beta0.91
RSI38.28
Earnings DateSep 3, 2025

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 33
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.